Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/18/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.27 | $114.1k | | 06/18/2021 |
06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.58 | $119k | | 06/26/2020 |
06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 13.6k | $7.58 | $102.7k | | 06/26/2020 |
05/06/2020 | Neon Therapeutics, Inc. | NTGN | Disposition | Stock Option (Right to Buy) | 14k | $16.00 | $224k | | 05/06/2020 |
05/06/2020 | Neon Therapeutics, Inc. | NTGN | Disposition | Stock Option (Right to Buy) | 18.5k | $4.64 | $85.8k | | 05/06/2020 |
06/25/2019 | Neon Therapeutics, Inc. | NTGN | Grant | Stock Option (Right to Buy) | 18.5k | $4.64 | $85.8k | | 06/25/2019 |
06/12/2019 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $4.46 | $70k | | 06/12/2019 |
06/29/2018 | Neon Therapeutics, Inc. | NTGN | Conversion | Series B Preferred Stock | 0 | $0.00 | $0 | See footnote | 06/29/2018 |
06/19/2018 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 13.6k | $7.92 | $107.3k | | 06/19/2018 |
02/01/2017 | Jounce Therapeutics, Inc. | JNCE | Conversion | Series A Preferred Stock | 0 | $0.00 | $0 | See Footnote | 02/01/2017 |
02/01/2017 | Jounce Therapeutics, Inc. | JNCE | Conversion | Series A Preferred Stock | 0 | $0.00 | $0 | See Footnote | 02/01/2017 |
06/08/2016 | Carisma Therapeutics Inc. | SESN | Grant | Stock Option | 8.1k | $1.83 | $14.8k | | 06/08/2016 |